An Open-label Randomised Trial to Assess the Therapeutic Efficacy and Tolerability of Arterolane-piperaquine Plus Single Low Dose Primaquine Versus Arterolane-piperaquine Plus Mefloquine and Single Low Dose Primaquine Versus Artemether-lumefantrine Plus Single Low Dose Primaquine in the Treatment of Uncomplicated Falciparum Malaria in Children in Kenya
Latest Information Update: 03 Dec 2021
At a glance
- Drugs Artemether/lumefantrine (Primary) ; Arterolane/piperaquine (Primary) ; Mefloquine (Primary) ; Primaquine (Primary)
- Indications Falciparum malaria
- Focus Therapeutic Use
- Acronyms TACTKenya
- 03 Dec 2021 New trial record